# Maternal vitamin D status in relation to cardiometabolic risk factors in children from the Norwegian Environmental Biobank

## TL;DR

This study explores how a mother's vitamin D levels during pregnancy may affect her child's cardiometabolic health, finding a link to higher adiponectin levels.

## Contribution

The study identifies a novel association between maternal vitamin D levels and childhood adiponectin z-scores.

## Key findings

- Higher maternal vitamin D levels were linked to increased childhood adiponectin z-scores.
- No associations were found between maternal vitamin D and other cardiometabolic risk factors in children.
- The study suggests adiponectin may be a potential pathway linking vitamin D to cardiometabolic health.

## Abstract

Maternal 25-hydroxyvitamin D (25OHD) status has been associated with birth weight and childhood growth. Further, maternal 25OHD status may also influence cardiometabolic outcomes in childhood. This study investigated the association between maternal 25OHD concentration in pregnancy and markers of cardiometabolic risk in 7–12-year-old children.

Data were obtained from the Norwegian Environmental Biobank (NEB) including 244 mother-child pairs in the Norwegian Mother, Father and Child Cohort Study (MoBa) participating in NEB part I and II. Childhood outcomes investigated were z-scores of anthropometrics, blood lipids and hormones. Associations between maternal 25OHD and individual cardiometabolic risk factors in children were assessed by linear regression, adjusted for maternal pre-pregnancy BMI, maternal education, child’s sex, age and BMI, and tested for interaction with pre-pregnancy BMI.

Per 10 nmol/L increase in maternal 25OHD, childhood adiponectin z-score increased by 0.067 standard deviations (p = 0.039). There were no associations between maternal 25OHD concentration and any other cardiometabolic risk factor in childhood.

The results indicate that higher maternal vitamin D status during pregnancy may be related to higher childhood adiponectin z-score, but not with any other cardiometabolic risk marker. Whether adiponectin could be one pathway linking vitamin D to cardiometabolic health remains to be determined.